InvestorNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Enters 1st Commercial Supply Agreement for Cannabigerol

June 10, 2021 09:28:05
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a biotechnology company producing ultra-pure, sustainably made compounds, and Cellular Goods PLC (LSE: CBX), a U.K.-based provider of premium consumer products based on biosynthetically made cannabinoids, today announced that the companies have entered into a multi-year supply agreement. Under the agreement, Willow will supply Cellular Goods with its proprietary, ultra-pure, biosynthetically produced cannabigerol (“Willow CBG”) to be used in Cellular Goods’ premium cannabinoid-based skin care products to be launched in autumn of 2021. “We are very excited to announce our first commercial supply agreement for CBG,” said Trevor Peters, Willow’s president and CEO. “In just over two years we have gone from proof of concept in the lab to commercial scale up and sales of our first cannabinoid, which will be slated for use in a consumer product. Cellular Goods are at the forefront, developing premium consumer cannabinoid products in the United Kingdom and we are thrilled to be supplying them with our ultra-pure, biosynthetically made CBG.” To view the full press release, visit About Willow Biosciences Inc. Willow is a Canadian biotechnology company that develops and produces high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Willow’s manufacturing process creates a consistent, scalable and sustainable product that benefits industry and consumers. Willow’s team has a proven track record of developing and commercializing bio-based manufacturing processes and products for both the consumer and pharmaceutical industries. For more information, visit the company’s website at NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.